These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16673674)

  • 21. Weighting must wait: incorporating equity concerns into cost-effectiveness analysis may take longer than expected.
    Wailoo A; Tsuchiya A; McCabe C
    Pharmacoeconomics; 2009; 27(12):983-9. PubMed ID: 19908923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of decision maker preferences for equity/efficiency attributes in reimbursement decisions in three European countries.
    Baji P; García-Goñi M; Gulácsi L; Mentzakis E; Paolucci F
    Eur J Health Econ; 2016 Sep; 17(7):791-9. PubMed ID: 26296623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of non-economic criteria in pricing and reimbursement decisions in Central and Eastern Europe: issues, trends and recommendations.
    Kolasa K; Kalo Z; Zah V
    Expert Rev Pharmacoecon Outcomes Res; 2016 Aug; 16(4):483-8. PubMed ID: 27467881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brexit and trade policy: an analysis of the governance of UK trade policy and what it means for health and social justice.
    van Schalkwyk MCI; Barlow P; Siles-Brügge G; Jarman H; Hervey T; McKee M
    Global Health; 2021 Jun; 17(1):61. PubMed ID: 34107982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Social values and health priority setting in Australia: an analysis applied to the context of health technology assessment.
    Whitty JA; Littlejohns P
    Health Policy; 2015 Feb; 119(2):127-36. PubMed ID: 25267072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A nonparametric elicitation of the equity-efficiency trade-off in cost-utility analysis.
    Bleichrodt H; Doctor J; Stolk E
    J Health Econ; 2005 Jul; 24(4):655-78. PubMed ID: 15960990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Equity trade-offs in conservation decision making.
    Law EA; Bennett NJ; Ives CD; Friedman R; Davis KJ; Archibald C; Wilson KA
    Conserv Biol; 2018 Apr; 32(2):294-303. PubMed ID: 28861904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reconciliation of economic concerns and health policy: illustration of an equity adjustment procedure using proportional shortfall.
    Stolk EA; van Donselaar G; Brouwer WB; Busschbach JJ
    Pharmacoeconomics; 2004; 22(17):1097-107. PubMed ID: 15612829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple criteria decision analysis in the context of health technology assessment: a simulation exercise on metastatic colorectal cancer with multiple stakeholders in the English setting.
    Angelis A; Montibeller G; Hochhauser D; Kanavos P
    BMC Med Inform Decis Mak; 2017 Oct; 17(1):149. PubMed ID: 29073892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HEALTH TECHNOLOGY ASSESSMENT, DELIBERATIVE PROCESS, AND ETHICALLY CONTESTED ISSUES.
    Daniels N; van der Wilt GJ
    Int J Technol Assess Health Care; 2016 Jan; 32(1-2):10-5. PubMed ID: 27472157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Social and ethical analysis in health technology assessment.
    Tantivess S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S81-6. PubMed ID: 24964703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bedside rationing by general practitioners: a postal survey in the Danish public healthcare system.
    Lauridsen SM; Norup M; Rossel P
    BMC Health Serv Res; 2008 Sep; 8():192. PubMed ID: 18808694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aggregate Distributional Cost-Effectiveness Analysis of Health Technologies.
    Love-Koh J; Cookson R; Gutacker N; Patton T; Griffin S
    Value Health; 2019 May; 22(5):518-526. PubMed ID: 31104729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advocacy for health equity: a synthesis review.
    Farrer L; Marinetti C; Cavaco YK; Costongs C
    Milbank Q; 2015 Jun; 93(2):392-437. PubMed ID: 26044634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey.
    Vokó Z; Cheung KL; Józwiak-Hagymásy J; Wolfenstetter S; Jones T; Muñoz C; Evers SM; Hiligsmann M; de Vries H; Pokhrel S;
    Health Res Policy Syst; 2016 May; 14(1):38. PubMed ID: 27230485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EXPLORING VALUES OF HEALTH TECHNOLOGY ASSESSMENT AGENCIES USING REFLECTIVE MULTICRITERIA AND RARE DISEASE CASE.
    Goetghebeur MM; Wagner M; Samaha D; O'Neil W; Badgley D; Castro-Jaramillo H; Abrishami P; Sarria-Santamera A; Cleemput I; Tringali M
    Int J Technol Assess Health Care; 2017 Jan; 33(4):504-520. PubMed ID: 29019295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilitarianism and the ethical foundations of cost-effectiveness analysis in resource allocation for global health.
    Marseille E; Kahn JG
    Philos Ethics Humanit Med; 2019 Apr; 14(1):5. PubMed ID: 30944009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and implementation of health technology assessment in Argentina: two steps forward and one step back.
    Rubinstein A; Pichon-Riviere A; Augustovski F
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():260-9. PubMed ID: 19527545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nudge for justice: An ERP investigation of default effects on trade-offs between equity and efficiency.
    Yu J; Wang Y; Yu J; Zhang G; Cong F
    Neuropsychologia; 2020 Dec; 149():107663. PubMed ID: 33129889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health system and equity perspectives in health technology assessment.
    Hanvoravongchai P
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S74-87. PubMed ID: 19253490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.